Formycon

Formycon is a leading, independent developer of high-quality follow-on biologics. The company focuses on treatments for ophthalmology, immunology, and other key chronic diseases, covering the entire value chain from technical development to Phase III clinical trials, as well as preparing dossiers for market approval. Formycon has made significant contributions to providing life-saving and affordable medicines to as many patients as possible through its biosimilars. Currently, Formycon has four biosimilars in development.